Kalbe Financial Statements From 2010 to 2026
| PTKFY Stock | USD 14.30 0.21 1.45% |
Check Kalbe Farma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalbe Farma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Kalbe financial statements analysis is a perfect complement when working with Kalbe Farma Valuation or Volatility modules.
Kalbe |
Kalbe Farma Tbk Company Return On Equity Analysis
Kalbe Farma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Kalbe Farma Return On Equity | 0.17 |
Most of Kalbe Farma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kalbe Farma Tbk is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Kalbe Farma Tbk has a Return On Equity of 0.1673. This is 100.7% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The return on equity for all United States stocks is 153.97% lower than that of the firm.
Kalbe Farma Tbk Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kalbe Farma's current stock value. Our valuation model uses many indicators to compare Kalbe Farma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kalbe Farma competition to find correlations between indicators driving Kalbe Farma's intrinsic value. More Info.Kalbe Farma Tbk is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers reporting about 0.63 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kalbe Farma Tbk is roughly 1.58 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kalbe Farma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kalbe Farma's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Kalbe Farma Financial Statements
Kalbe Farma investors use historical fundamental indicators, such as Kalbe Farma's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalbe Farma. Please read more on our technical analysis and fundamental analysis pages.
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia. Pt Kalbe operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 12501 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Kalbe Pink Sheet Analysis
When running Kalbe Farma's price analysis, check to measure Kalbe Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalbe Farma is operating at the current time. Most of Kalbe Farma's value examination focuses on studying past and present price action to predict the probability of Kalbe Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalbe Farma's price. Additionally, you may evaluate how the addition of Kalbe Farma to your portfolios can decrease your overall portfolio volatility.